Transcranial Direct Current Stimulation for Migraine Attack

This study is conducted to investigate the therapeutic efficacy and safety of transcranial direct current stimulation (tDCS) over the primary motor cortex of patients with acute migraine attack.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Migraine

Age range

17 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Seoul National University Hospital

Seoul, 110-744, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Aged 17-70 years
Migraine

With or without aura
The first attack of migraine was earlier than 50 years of age
One to 8 moderate to severe migraine attacks per month in the 2 months preceding the screening
Willing and able to give written informed consent
Able to read, comprehend and complete the diary form

Exclusion criteria

Not able to distinguish between migraine and non-migraine headache
Combined headache, including the tension type headache and medication overuse headache
Pregnant, actively trying to become pregnant or breast-feeding women
Uncontrolled and significant medical illness
Vertebrobasilar or hemiplegic migraine according to the International Headache Society diagnostic criteria
Having intracranial metal implants or a cardiac pacemaker
A history of epilepsy or other organic brain disorders
A history of psychological diseases
Having changed medications for migraine within 1 month before giving us informed consent
Drug abuser or alcoholics

Treatment and study plan

transcranial direct current stimulation

Procedure

A constant current of 2 mA intensity applied for 20 min over C3 or C4

Primary outcomes

Number of participants who experienced pain relief of one level or more

Time frame: at 2h post-treatment

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Registry information

Official study title

Manho Kim, MD, PhD Professor, Neurology Seoul National University Hospital,

Important dates

Study start: 2009
Primary completion: 2009
Study completion: 2011
First posted: May 23, 2011
Registry last updated: Oct 25, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed